文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

低潮气量-气道压力释放通气方案与传统气道压力释放通气及容量控制通气方案的随机可行性试验

Randomized Feasibility Trial of a Low Tidal Volume-Airway Pressure Release Ventilation Protocol Compared With Traditional Airway Pressure Release Ventilation and Volume Control Ventilation Protocols.
PubMed 文献 · Crit Care Med · 2018-01-01
一句话结论在急性低氧性呼吸衰竭成人ICU患者中,气道压力释放通气(APRV)释放潮气量常超过12 mL/kg,现有APRV方案无法一致实现低潮气量通气目标。

这项前瞻性随机试验计划纳入246例急性低氧性呼吸衰竭成人ICU患者,随机分为低潮气量-容量控制、低潮气量-气道压力释放通气(APRV)和传统APRV三组,因入组缓慢且低潮气量-APRV组无法稳定达到潮气量低于6.5 mL/kg而提前终止。APRV组释放潮气量为8.6 mL/kg(95%CI 7.8-9.6),低潮气量-APRV组为8.0 mL/kg(95%CI 7.3-8.9),均高于容量控制组的6.8 mL/kg(95%CI 6.2-7.5;p=0.005),APRV与低潮气量-APRV组间无差异(p=0.58)。52例患者第3天PaO2/FIO2无差异(p=0.92),镇静、血管活性药物使用或气胸发生无显著差异。作者认为,在缺乏明确、可推广且可重复的低潮气量-APRV方案前,大规模低潮气量-APRV疗效试验不可行。

要点

  • APRV释放潮气量常超过12 mL/kg,即使采用旨在实现低潮气量通气的方案也无法避免。
  • 低潮气量-APRV组潮气量8.0 mL/kg(95%CI 7.3-8.9)与APRV组8.6 mL/kg(95%CI 7.8-9.6)均高于容量控制组6.8 mL/kg(95%CI 6.2-7.5),p=0.005。
  • APRV与低潮气量-APRV组间潮气量无差异(p=0.58)。
  • 52例患者第3天PaO2/FIO2无差异(p=0.92),镇静、血管活性药物或气胸发生无显著差异。
  • 现有APRV方案无法一致、可重复地实现低潮气量通气目标,大规模疗效试验目前不可行。

适用人群与场景

  • 成人ICU患者,急性低氧性呼吸衰竭,预期需要长时间机械通气。
  • 来自四个InterMountain Healthcare三级ICU。

研究设计与关键结果

  • 前瞻性随机试验,计划纳入246例,因入组缓慢及低潮气量-APRV组无法稳定达到潮气量低于6.5 mL/kg而提前终止。
  • APRV组释放潮气量8.6 mL/kg(95%CI 7.8-9.6),低潮气量-APRV组8.0 mL/kg(95%CI 7.3-8.9),容量控制组6.8 mL/kg(95%CI 6.2-7.5),p=0.005;APRV与低潮气量-APRV组间p=0.58。
  • 52例患者第3天PaO2/FIO2无差异(p=0.92)。
  • 镇静、血管活性药物使用或气胸发生各组间无显著差异。
  • APRV释放潮气量常超过12 mL/kg。

证据类型、等级与局限

  • 证据类型:前瞻性随机可行性试验。
  • 局限:样本量小(52例第3天PaO2/FIO2分析);因入组缓慢和无法稳定达到低潮气量目标而提前终止;作者指出当前APRV方案无法一致可重复实现低潮气量通气目标,大规模疗效试验目前不可行。

对床旁实践的改变

  • 作者认为,在缺乏明确、可推广且可重复的低潮气量-APRV方案前,不应开展大规模低潮气量-APRV疗效试验。
  • 临床使用APRV时需注意释放潮气量可能常超过12 mL/kg,无法稳定达到低潮气量通气目标。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Low tidal volume (= tidal volume ≤ 6 mL/kg, predicted body weight) ventilation using volume control benefits patients with acute respiratory distress syndrome. Airway pressure release ventilation is an alternative to low tidal volume-volume control ventilation, but the release breaths generated are variable and can exceed tidal volume breaths of low tidal volume-volume control. We evaluate the application of a low tidal volume-compatible airway pressure release ventilation protocol that manages release volumes on both clinical and feasibility endpoints.

DESIGN: We designed a prospective randomized trial in patients with acute hypoxemic respiratory failure. We randomized patients to low tidal volume-volume control, low tidal volume-airway pressure release ventilation, and traditional airway pressure release ventilation with a planned enrollment of 246 patients. The study was stopped early because of low enrollment and inability to consistently achieve tidal volumes less than 6.5 mL/kg in the low tidal volume-airway pressure release ventilation arm. Although the primary clinical study endpoint was PaO2/FIO2 on study day 3, we highlight the feasibility outcomes related to tidal volumes in both arms.

SETTING: Four Intermountain Healthcare tertiary ICUs.

PATIENTS: Adult ICU patients with hypoxemic respiratory failure anticipated to require prolonged mechanical ventilation.

INTERVENTIONS: Low tidal volume-volume control, airway pressure release ventilation, and low tidal volume-airway pressure release ventilation.

MEASUREMENTS AND MAIN RESULTS: We observed wide variability and higher tidal (release for airway pressure release ventilation) volumes in both airway pressure release ventilation (8.6 mL/kg; 95% CI, 7.8-9.6) and low tidal volume-airway pressure release ventilation (8.0; 95% CI, 7.3-8.9) than volume control (6.8; 95% CI, 6.2-7.5; p = 0.005) with no difference between airway pressure release ventilation and low tidal volume-airway pressure release ventilation (p = 0.58). Recognizing the limitations of small sample size, we observed no difference in 52 patients in day 3 PaO2/ FIO2 (p = 0.92). We also observed no significant difference between arms in sedation, vasoactive medications, or occurrence of pneumothorax.

CONCLUSIONS: Airway pressure release ventilation resulted in release volumes often exceeding 12 mL/kg despite a protocol designed to target low tidal volume ventilation. Current airway pressure release ventilation protocols are unable to achieve consistent and reproducible delivery of low tidal volume ventilation goals. A large-scale efficacy trial of low tidal volume-airway pressure release ventilation is not feasible at this time in the absence of an explicit, generalizable, and reproducible low tidal volume-airway pressure release ventilation protocol.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Hirshberg EL, Lanspa MJ, Peterson J, et al. Randomized Feasibility Trial of a Low Tidal Volume-Airway Pressure Release Ventilation Protocol Compared With Traditional Airway Pressure Release Ventilation and Volume Control Ventilation Protocols. Crit Care Med. 2018. PMID: 30277890. doi:10.1097/CCM.0000000000003437

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。